Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 22, 2008

View Archived Issues

Adoptive transfer of T cells loaded with oncolytic virus effective in eliminating cancer metastasis

Endothelial progenitor cells regulate the angiogenic switch in lung metastasis model

Promising preclinical results of novel broadly neutralizing antibodies against HCV infection

Eisai granted early termination of statutory waiting period in acquisition of MGI

Novel therapeutic agents for hematologic disorders reported in recent patent literature

Adherex initiates phase IIb clinical trial of ADH-1 for melanoma

Senexis secures new funding to develop innovative compounds for AD

Angiotech and Symphony enter licensing agreement for PEG-based biomaterials

Primary endpoint met in phase II trial of 2PX for osteoarthritis

Peptimmune completes first close of series D preferred stock offering

Genaera initiates phase I trial of trodusquemine in overweight and obese diabetic patients

Preclinical characterization of aripiprazole shows uniqueness of D2 partial agonists

Cleveland BioLabs' Protectan CBLB-502 not selected for defense contract award

Diamyd submits application to initiate phase III studies of Diamyd in Sweden

Decreased VLDLR expression may be a biomarker for schizophrenia

Cerepro phase III trial results expected in July 2008

FDA committee to consider two injectable antibiotics from Theravance and J&J

GSK will not option XL-784 for further development

Recent Novartis patent discloses novel antiasthmatic agents

Schering-Plough and Shionogi launch Claritin dry syrup 1%

Motilin receptor agonists described in recent GSK patent

Roche and Ventana sign definitive merger agreement

Promising results for GW cannabinoid treatments for diabetes and metabolic disorders

Progress from Arpida's pivotal phase III trial of TLT treatment in onychomycosis

New treatment option for psoriasis imparted in recent Nippon Shinyaku patent

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...